Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer
- 30 June 2006
- journal article
- clinical trial
- Published by Elsevier BV in Lung Cancer
- Vol. 52 (3), 349-357
- https://doi.org/10.1016/j.lungcan.2006.01.011
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Clinical significance of bone marrow microinvolvement in nonsmall cell lung carcinomaCancer, 2004
- Transcription of Cytokeratins 8, 18, and 19 in Bone Marrow and Limited Expression of Cytokeratins 7 and 20 by Carcinoma Cells: Inherent Limitations for RT-PCR in the Detection of Isolated Tumor CellsLaboratory Investigation, 2001
- Development of Matrix Metalloproteinase Inhibitors in Cancer TherapyJNCI Journal of the National Cancer Institute, 2001
- Bone-marrow microinvolvement in non-small cell lung cancer is not a reliable indicator of tumour recurrence and prognosisEuropean Journal of Surgical Oncology, 2000
- Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCREuropean Journal of Cancer, 2000
- Matrix Metalloproteinases: Biologic Activity and Clinical ImplicationsJournal of Clinical Oncology, 2000
- Preclinical and Clinical Studies of MMP Inhibitors in CancerAnnals of the New York Academy of Sciences, 1999
- The plasmin cascade and matrix metalloproteinases in non-small cell lung cancerThorax, 1999
- Changing views of the role of matrix metalloproteinases in metastasisJNCI Journal of the National Cancer Institute, 1997
- Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinicSeminars in Cancer Biology, 1996